PA
NUVB icon

Profund Advisors’s Nuvation Bio NUVB Stock Holding History

Profund Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$235K Buy
54,789
+18,269
+50% +$102K 0.01% 927
2025
Q4 		$327K Sell
36,520
-22,470
-38% -$139K 0.01% 808
2025
Q3 		$218K Buy
58,990
+11,393
+24% +$31K 0.01% 930
2025
Q2 		$92.8K Buy
47,597
+7,123
+18% +$14.8K ﹤0.01% 968
2025
Q1 		$71.2K Buy
40,474
+9,195
+29% +$20.9K ﹤0.01% 971
2024
Q4 		$83.2K Sell
31,279
-136
-0.4% -$350 ﹤0.01% 1083
2024
Q3 		$71.9K Buy
31,415
+9,695
+45% +$29.6K ﹤0.01% 1123
2024
Q2 		$63.4K Buy
+21,720
New +$66.3K ﹤0.01% 1064
2023
Q1 		– Sell
-12,133
Closed -$23.3K – 1139
2022
Q4 		$23.3K Buy
12,133
+699
+6% +$1.41K ﹤0.01% 999
2022
Q3 		$26K Buy
11,434
+1,304
+13% +$3.72K ﹤0.01% 917
2022
Q2 		$33K Sell
10,130
-1,571
-13% -$6.85K ﹤0.01% 1010
2022
Q1 		$62K Sell
11,701
-916
-7% -$5.15K ﹤0.01% 1337
2021
Q4 		$107K Buy
+12,617
New +$116K ﹤0.01% 1339

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Profund Advisors's NUVB Position: Q1 2026 in Review

Profund Advisors increased its Nuvation Bio (NUVB) stake by 50% in Q1 2026, buying an estimated $102K and bringing the position to 54,789 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #927.

Profund Advisors first reported a position in NUVB in Q4 2021 and has held it in 13 quarters since. The position peaked at $327K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Profund Advisors held 54,789 shares of Nuvation Bio worth $235K as of Q1 2026.
  • Profund Advisors bought 18,269 Nuvation Bio shares in Q1 2026, an estimated $102K.
  • Nuvation Bio made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #927 holding.
  • Profund Advisors first reported a position in Nuvation Bio in Q4 2021 and has held it in 13 quarters since.
  • Profund Advisors's Nuvation Bio position peaked at $327K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.